What is Evommune 's lease payments?

Evommune (EVMN) reported lease payments of $90.99K in Q1 2026.

What does lease payments mean?

The total cash outflows made by the company to satisfy obligations under operating lease agreements for assets such as office space or equipment. This metric is used to evaluate the company's fixed cash commitments and ongoing operational overhead.

Evommune EVMN Lease Payments

Lease Payments at other companies

Schneider NationalSNDR

$10.5M+1.0%

Healthcare Services GroupHCSG

$1.58M-28.6%

ALH

Alliance Laundry Holdings Inc.ALH

$1.51M-0.9%

John Wiley & Sons, Inc.WLYB

$5.21M-10.9%

Willdan GroupWLDN

$1.55M-9.4%

Capital City Bank GroupCCBG

$920K+0.9%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeasePayments.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's lease payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's lease payments?: Evommune (EVMN) reported lease payments of $90.99K in Q1 2026.
What does lease payments mean?: The total cash outflows made by the company to satisfy obligations under operating lease agreements for assets such as office space or equipment. This metric is used to evaluate the company's fixed cash commitments and ongoing operational overhead.